HighTide Therapeutics Appoints Daniel Ripley as SVP Business Development
Copyright 2022, Business Wire.
news
2022-10-20 14:00:00

October 20, 2022 10:00 AM Eastern Daylight Time ROCKVILLE, Md. & SHENZHEN, China--(BUSINESS WIRE)--HighTide Therapeutics, Inc. ('HighTide'), a clinical-stage biopharmaceutical company developing multifunctional therapies for metabolic and digestive diseases, today announced the appointment of Daniel Ripley as Senior Vice President of Business Development.



Mr. Ripley has 25 years of experience in pharmaceutical business development. Most recently he served as Head of Global Business Development for Alpha Biopharma.
